ATS Corporation (ATS)
| Market Cap | 3.37B +35.9% |
| Revenue (ttm) | 2.05B +1.8% |
| Net Income | 13.81M -78.8% |
| EPS | 0.14 -79.1% |
| Shares Out | 98.06M |
| PE Ratio | 241.30 |
| Forward PE | 22.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,748 |
| Open | 34.22 |
| Previous Close | 34.25 |
| Day's Range | 32.89 - 34.22 |
| 52-Week Range | 23.85 - 35.70 |
| Beta | 1.27 |
| Analysts | Hold |
| Price Target | 35.00 (+6.13%) |
| Earnings Date | May 27, 2026 |
About ATS
ATS Corporation, together with its subsidiaries, provides automation solutions worldwide. The company is involved in planning, designing, building, commissioning, and servicing automated manufacturing and assembly systems, including automation products and test solutions. It also offers pre-automation services comprising discovery and analysis, concept development, simulation, and total cost of ownership modelling; post-automation services, including training, process optimization, preventative maintenance, emergency and on-call support, spare ... [Read more]
Analyst Summary
According to one analyst, the rating for ATS stock is "Hold" and the 12-month stock price target is $35.0.
News
Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
Primary and subgroup analysis from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough accepted for oral presentation, including key subgroup analyse...
ATS Corporation price target raised to C$51 from C$48 at Scotiabank
Scotiabank raised the firm’s price target on ATS Corporation (ATS) to C$51 from C$48 and keeps an Outperform rating on the shares.
ATS Corporation price target lowered to $30 from $31 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on ATS Corporation (ATS) to $30 from $31 and keeps a Sell rating on the shares. The firm is updating its models as
ATS to Participate in the TD Cowen Distinctive Industrials and Infrastructure Services Conference
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright, Chief Executive Officer, and Anne Cybulski, Interim Chief Financi...
ATS Corporation Transcript: 47th Annual Raymond James Institutional Investor Conference
The incoming CEO outlined a strategy focused on margin expansion, disciplined M&A, and leveraging strengths in life sciences and nuclear markets. Operational improvements, portfolio diversification, and targeted investments in high-margin and service-oriented businesses are key priorities.
ATS to Participate in the Raymond James Institutional Investors Conference
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright, Chief Executive Officer, and Anne Cybulski, Interim Chief Financi...
ATS Corporation Earnings Call Transcript: Q3 2026
Q3 revenue rose 16.7% year-over-year to $761M, with strong growth in life sciences and energy. Order backlog remains robust at $2.1B, and margin expansion is a key focus. Capital allocation will prioritize M&A and innovation as leverage returns to target range.
ATS Corporation reports Q3 EPS 48c, consensus 32c
Reports Q3 revenue $760.7M, consensus $722.42M. “Today, ATS reported third quarter results for fiscal 2026,” said Doug Wright, CEO. “Results reflected solid organic revenue growth across our diversifi...
ATS Reports Third Quarter Fiscal 2026 Results
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX and NYSE: ATS) ("ATS" or the "Company") today reported its financial results for the three and nine months ended December 28, 2025. All refere...
ATS Corporation price target lowered to C$47 from C$49 at Scotiabank
Scotiabank analyst Jonathan Goldman lowered the firm’s price target on ATS Corporation (ATS) to C$47 from C$49 and keeps an Outperform rating on the shares.
ATS Corporation price target raised to C$48 from C$46 at TD Securities
TD Securities raised the firm’s price target on ATS Corporation (ATS) to C$48 from C$46 and keeps a Buy rating on the shares.
ATS to Host Third Quarter Earnings Call Wednesday February 4, 2026, at 8:30 a.m. Eastern
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the third quarter ended December 28, 2025, before markets ope...
ATS Corporation announces resignation of CFO Ryan McLeod
ATS Corporation (ATS) announced that Ryan McLeod has resigned from his role of Chief Financial Officer, CFO, to pursue an opportunity in an unrelated industry. The effective date for McLeod’s
ATS Announces CFO Resignation
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod has resigned from his role of Chief Financial Officer (“CFO”) to p...
ATS Corporation price target raised to $35 from $33 at JPMorgan
JPMorgan analyst Stephen Tusa raised the firm’s price target on ATS Corporation (ATS) to $35 from $33 and keeps a Neutral rating on the shares. The firm adjusted ratings and
ATS Corporation announces normal course issuer bid
ATS Corporation (ATS) announced that the Toronto Stock Exchange has accepted its intention to make a normal course issuer bid, or NCIB. As of December 10, 2025, ATS had a
ATS Announces Normal Course Issuer Bid
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”), today announced that the Toronto Stock Exchange (“TSX”) has accepted a notice filed by it of its inte...
ATS Corporation names Doug Wright as CEO
ATS Corporation (ATS) announced that Doug Wright has been appointed CEO and a member of its Board of Directors, commencing on or before January 14, 2026. Wright’s appointment follows a
ATS Announces Doug Wright as Chief Executive Officer
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright has been appointed Chief Executive Officer (CEO) and a member of i...
ATS to Participate in the UBS Global Industrials and Transportation Conference
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod, Interim Chief Executive Officer, and Anne Cybulski, Interim Chief...
ATS to Participate in the Goldman Sachs Industrials and Materials Conference
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod, Interim Chief Executive Officer, and Anne Cybulski, Interim Chief...
ATS Corporation Transcript: The Scotiabank Transportation & Industrials Conference
Interim leadership is guiding the company through a period of strong revenue growth, margin expansion, and strategic investments in high-growth sectors like Life Sciences and nuclear. The CEO search is well advanced, and operational continuity is maintained through a decentralized structure.
ATS to Participate in the Scotiabank Transportation & Industrials Conference
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod, Interim Chief Executive Officer, and Anne Cybulski, Interim Chief...
ATS Corporation upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank analyst Jonathan Goldman upgraded ATS Corporation (ATS) to Outperform from Sector Perform with a C$49 price target